Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation

American Journal of Transplantation

Volumn 10, Issue 4, 2010, Pages 900-907

  Pelaez, A ^a,b   Force, S D ^a,b   Gal, A A ^c   Neujahr, D C ^a,b   Ramirez, A M ^a,b   Naik, P M ^a   Quintero, D A ^a   Pileggi, A V ^d   Easley, K A ^d   Echeverry, R ^a   Lawrence, E C ^a,b   Guidot, D M ^a   Mitchell, P O ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Lung transplantation; Primary graft dysfunction; Receptor for advanced glycation end products RAGE; Reperfusion injury

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSBRONCHIAL BIOPSY;

BIOPSY; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; RECEPTORS, IMMUNOLOGIC; TISSUE DONORS;

EID: 77949825659     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02995.x     Document Type: Article

References (36)

1. Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998 114 : 51 60.
2. Christie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003 124 : 1232 1241.
3. King RC, Binns OA, Rodriguez F et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000 69 : 1681 1685.
4. Khan SU, Salloum J, O'Donovan PB et al. Acute pulmonary edema after lung transplantation: The pulmonary reimplantation response. Chest 1999 116 : 187 194.
5. Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005 171 : 1312 1316.
6. Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: Treatment. J Heart Lung Transplant 2005 24 : 1489 1500.
7. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003 167 : 490 511.
8. Ware LB, Wang Y, Fang X et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002 360 : 619 620.
9. Angel LF, Levine DJ, Restrepo MI et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006 174 : 710 716.
10. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999 159 : 980 988.
11. Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007 293 : L52 L59.
12. Burton CM, Iversen M, Milman N et al. Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 2007 31 : 75 82.
13. Katsuoka F, Kawakami Y, Arai T et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 1997 238 : 512 516.
14. Shirasawa M, Fujiwara N, Hirabayashi S et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004 9 : 165 174.
15. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009 135 : 269 275.
16. Calfee CS, Budev MM, Matthay MA et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant 2007 26 : 675 680.
17. Calfee CS, Ware LB, Eisner MD et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008 63 : 1083 1089.
18. Griffiths MJ, McAuley DF. RAGE: A biomarker for acute lung injury. Thorax 2008 63 : 1034 1036.
19. He M, Kubo H, Ishizawa K et al. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007 293 : L1427 L1436.
20. Sternberg DI, Gowda R, Mehra D et al. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg 2008 136 : 1576 1585.
21. Uchida T, Shirasawa M, Ware LB et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006 173 : 1008 1015.
22. Zhang H, Tasaka S, Shiraishi Y et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008 178 : 356 362.
23. Christie JD, Shah CV, Kawut SM et al. Plasma levels of receptor for advanced glycation end-products(sRAGE), blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 2009 180 : 1010 1015.
24. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005 24 : 1454 1459.
25. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005 24 : 1483 1488.
26. Pelaez A, Lyon GM, Force SD et al. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009 28 : 67 71.
27. Naik PM, Lyon GM, 3rd., Ramirez A et al. Dapsone-induced hemolytic anemia in lung allograft recipients. J Heart Lung Transplant 2008 27 : 1198 1202.
28. Hosmer DW, Lemeshow S. Applied logistic regression. New York : John Wiley and Sons 1989.
29. Fisher AJ, Donnelly SC, Hirani N et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001 163 : 259 265.
30. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg 2007 32 : 35 41.
31. Anraku M, Cameron MJ, Waddell TK et al. Impact of human donor lung gene expression profiles on survival after lung transplantation: A case-control study. Am J Transplant 2008 8 : 2140 2148.
32. Kaneda H, Waddell TK, de Perrot M et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant 2006 6 : 544 551.
33. Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am J Transplant 2007 7 : 2396 2405.
34. McElroy MC, Kasper M. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 2004 24 : 664 673.
35. Newman V, Gonzalez RF, Matthay MA, Dobbs LG. A novel alveolar type I cell-specific biochemical marker of human acute lung injury. Am J Respir Crit Care Med 2000 161 (3 Pt 1 990 995.
36. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001 163 : 1376 1383.